Mitochondria‐Targeting Oxidovanadium(IV) Complex as a Near‐IR Light Photocytotoxic Agent

Oxidovanadium(IV) complexes [VO(L¹)(phen)] ? Cl ( 1 ) and [VO(L²)(L³)] ? Cl ( 2 ), in which HL¹ is 2‐{[(benzimidazol‐2‐yl)methylimino]‐methyl}phenol (sal‐ambmz), HL² is 2‐[({1‐[(anthracen‐9‐yl)methyl]‐benzimidazol‐2‐yl}methylimino)‐methyl]phenol (sal‐an‐ambmz), phen is 1,10‐phenanthroline and L³ is dipyrido[3,2‐a:2′,3′‐c]phenazine (dppz) conjugated to a Gly‐Gly‐OMe dipeptide moiety, were prepared, characterized, and their DNA binding, photoinduced DNA‐cleavage, and photocytotoxic properties were studied. Fluorescence microscopy studies were performed by using complex 2 in HeLa and HaCaT cells. Complex 1 , structurally characterized by X‐ray crystallography, has a vanadyl group in VO₂N₄ core with the VO²⁺ moiety bonded to N,N‐donor phen and a N,N,O‐donor Schiff base. Complex 2 , having an anthracenyl fluorophore, showed fluorescence emission bands at 397, 419, and 443 nm. The complexes are redox‐active exhibiting the V(IV)/V(III) redox couple near ?0.85 V versus SCE in DMF 0.1 M tetrabutylammonium perchlorate (TBAP). Complex 2 , having a dipeptide moiety, showed specific binding towards poly(dAdT)₂ sequence. The dppz‐Gly‐Gly‐OMe complex showed significant DNA photocleavage activity in red light of 705 nm through a hydroxyl radical (^.OH) pathway. Complex 2 showed photocytotoxicity in HaCaT and HeLa cells in visible light (400–700 nm) and red light (620–700 nm), however, the complex was less toxic in the dark. Fluorescence microscopy revealed the localization of complex 2 primarily in mitochondria. Apoptosis was found to occur inside mitochondria (intrinsic pathway) caused by ROS generation.